Medicare billing address
CMS Medicare provider billing file
850 S 5Th StAllentown, PA 18103
CMS public data · NPI 1841426483
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Andrew G Reish, MD
Specialty
Credential
MD
NPI
1841426483
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Andrew G Reish, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
850 S 5Th StCMS Doctors & Clinicians file
3200 Ctr Valley PkwyCMS Doctors & Clinicians file
510 Brookmont DrCMS Doctors & Clinicians file
850 S 5Th StIn the 2024 CMS provider billing file, this NPI had 419 Medicare beneficiaries and 40,379 total services. The average beneficiary age was 73, and the average HCC risk score was 1.8.
Total Medicare allowed amount
$435,397.30
Total Medicare payment amount
$341,383.50
Medicare beneficiaries
419
Total services
40,379
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Mood disorders
52%
CMS beneficiary-panel share
Depression
45%
CMS beneficiary-panel share
Anxiety
42%
CMS beneficiary-panel share
Chronic kidney disease
38%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 34,400 | $6.10 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 367 | $120.18 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 258 | $74.24 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 193 | $88.83 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 93 | $66.27 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 93 | $110.98 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 91 | $84.88 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 60 | $83.75 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 57 | $0.94 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 56 | $158.06 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1841426483. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Baclofen | Baclofen | 108 | 162.2 | $3,048.11 |
| 2 | Gabapentin | Gabapentin | 64 | 130.3 | $633.58 |
| 3 | Pregabalin | Pregabalin | 49 | 61.1 | $556.07 |
| 4 | Botox | Onabotulinumtoxina | 38 | 113.4 | $84,890.17 |
| 5 | Diazepam | Diazepam | 30 | 30 | $38.04 |
| 6 | Tizanidine Hcl | Tizanidine Hcl | 26 | 44 | $2,562.95 |
| 7 | Duloxetine Hcl | Duloxetine Hcl | 20 | 32 | $332.89 |
| 8 | Dysport | Abobotulinumtoxina | 15 | 44.6 | $22,485.40 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Virginia School Of Medicine
Graduation year
2008
Group/practice field
Good Shepherd Rehabilitation Hospital
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.